FIRST AMENDMENT TO THE CONTRACT RESEARCH AGREEMENTContract Research Agreement • March 10th, 2009 • Exelixis Inc • Services-commercial physical & biological research
Contract Type FiledMarch 10th, 2009 Company IndustryThis FIRST AMENDMENT TO THE CONTRACT RESEARCH AGREEMENT (the “Amendment”) is made and entered into by and between AGRIGENETICS, INC., a Delaware corporation having its principal place of business at 9330 Zionsville Road, Indianapolis, Indiana 46268 (“Agrigenetics”) and EXELIXIS PLANT SCIENCES, INC., a Delaware corporation having its principal place of business at 16160 SW Upper Boones Ferry Road, Portland, Oregon 97224 (“EPS”). Agrigenetics and EPS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
AMENDMENT NO. 1 TO THE COLLABORATION AGREEMENT BETWEEN EXELIXIS, INC., AND BRISTOL-MYERS SQUIBB COMPANYCollaboration Agreement • March 10th, 2009 • Exelixis Inc • Services-commercial physical & biological research
Contract Type FiledMarch 10th, 2009 Company IndustryTHIS AMENDMENT NO. 1 (“Amendment No. 1”) to the Agreement (defined below) is effective on December 17, 2008 (the “Amendment No. 1 Effective Date”) by and between Exelixis, Inc., a Delaware corporation located at 170 Harbor Way, P.O. Box 511, South San Francisco, California 94083-0511 (“Exelixis”) and Bristol-Myers Squibb Company, a Delaware corporation headquartered at 345 Park Avenue, New York, New York 10154 (“BMS”). Exelixis and BMS may be referred to individually as a “Party” and collectively as the “Parties”.
COLLABORATION AGREEMENTCollaboration Agreement • March 10th, 2009 • Exelixis Inc • Services-commercial physical & biological research • Delaware
Contract Type FiledMarch 10th, 2009 Company Industry JurisdictionTHIS COLLABORATION AGREEMENT (the “Agreement”) is made and entered into as of December 11, 2008 (the “Execution Date”) by and between EXELIXIS, INC., a Delaware corporation having its principal place of business at 170 Harbor Way, P.O. Box 511, South San Francisco, California 94083-0511 (“Exelixis”), and BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation headquartered at 345 Park Avenue, New York, New York, 10154 (“BMS”). Exelixis and BMS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
SECOND AMENDMENT TO THE CONTRACT RESEARCH AGREEMENTContract Research Agreement • March 10th, 2009 • Exelixis Inc • Services-commercial physical & biological research
Contract Type FiledMarch 10th, 2009 Company IndustryThis SECOND AMENDMENT TO THE CONTRACT RESEARCH AGREEMENT (the “Amendment”) is made and entered into by and between AGRIGENETICS, INC., a Delaware corporation having its principal place of business at 9330 Zionsville Road, Indianapolis, Indiana 46268 (“Agrigenetics”) and EXELIXIS PLANT SCIENCES, INC., a Delaware corporation having its principal place of business at 16160 SW Upper Boones Ferry Road, Portland, Oregon 97224 (“EPS”). Agrigenetics and EPS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
SECOND AMENDMENT TO LEASELease Agreement • March 10th, 2009 • Exelixis Inc • Services-commercial physical & biological research
Contract Type FiledMarch 10th, 2009 Company IndustryTHIS SECOND AMENDMENT TO LEASE (this “Second Amendment”) is made as of October 23, 2008, by and between ARE-SAN FRANCISCO NO. 12, LLC, a Delaware limited liability company (“Landlord”), and EXELIXIS, INC., a Delaware corporation (“Tenant”).
THIRD AMENDMENT TO LEASELease Agreement • March 10th, 2009 • Exelixis Inc • Services-commercial physical & biological research
Contract Type FiledMarch 10th, 2009 Company IndustryTHIS THIRD AMENDMENT TO LEASE (this “Third Amendment”) is made as of October 24, 2008, by and between ARE-SAN FRANCISCO NO. 12, LLC, a Delaware limited liability company (“Landlord”), and EXELIXIS, INC., a Delaware corporation (“Tenant”).
ContractCollaboration Agreement • March 10th, 2009 • Exelixis Inc • Services-commercial physical & biological research • New York
Contract Type FiledMarch 10th, 2009 Company Industry Jurisdiction[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.